ArticleBMC women's health2025
Factors associated with cervical cancer screening among women attending maternal child health clinics in Kenya.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundCervical cancer is the second leading malignancy in incidence among women in sub-Saharan Africa. Early detection through screening and treatment of pre-cancerous cervical lesions is paramount in preventing cervical cancer. We sought to examine factors associated with ever being screened for cervical cancer among women attending infant immunization clinics in Kenya.
methodsWe conducted secondary data analysis from a cross-sectional survey that enrolled mother-infant pairs attending 55 infant immunization clinics in Kenya between 2018 and 2019. Clinics were selected from high and medium/low HIV-burden counties using probability-proportionate-to-size sampling. The primary outcome was self-reported cervical cancer screening. To align with the target age group for cervical cancer screening in Kenya, we excluded women less than 25 years old. Factors associated with cervical cancer screening were assessed using generalized Poisson regression models accounting for survey design.
resultsOverall, 970 of 1488 women were aged ≥ 25 years and had cervical cancer screening information available. Of these, 24% reported history of cervical cancer screening. Of the women screened, 76.5% had one prior screening and 38.7% underwent screening within the previous year. Among women previously screened, 4% reported an abnormal screening result, of which 18% received treatment. Cervical cancer screening was reported in 32.3% of women living with HIV (WLWH) and 16.3% of HIV-uninfected women (P < 0.001). In multivariable analysis, screening prevalence was higher in WLWH than HIV-uninfected women (adjusted Prevalence Ratio [aPR] = 1.67, 95% confidence interval [CI]: 1.25-2.25), employed than unemployed women (aPR = 1.48, 95% CI: 1.11-1.96), and those from high HIV-burden counties compared to medium/low HIV-burden counties (aPR = 1.30, 95% CI: 0.89-1.91). Among WLWH, longer antiretroviral therapy duration (> 2 years) and being from a high HIV-burden county were associated with screening prevalence, although these associations for high burden county were attenuated after adjustment (aPR = 1.65, 95% CI: 1.14-2.39 and aPR = 1.50, 95% CI: 0.91-2.49, respectively). Among HIV-uninfected women, older age (≥ 30 years) and being employed were associated with higher screening prevalence.
conclusionCervical cancer screening and linkage to treatment for women with abnormal results was low among women aged ≥ 25 years attending immunization clinics in Kenya. Higher screening uptake in WLWH and in high HIV-burden counties was presumably due to the integration of cervical cancer screening within HIV care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.